In comparison to Schreuder’s study [13], our fat challenge was considerably higher, which could have contributed to differential findings at single postprandial time points and in FGF19-IAUC between controls and NAFLD patients. The gene discussed is FGF19; the disease is metabolic dysfunction-associated steatotic liver disease.